comparemela.com

Latest Breaking News On - Biosearch technologies - Page 10 : comparemela.com

Tackling the rise of variants with novel monitoring assays

Editorial Article: Keeping up with COVID-19: Designing novel monitoring assays to tackle the rise of variants Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response 28 Apr 2021 Dr. Tania Nolan, head of assay design and development at LGC, Biosearch Technologies Growing concern over the emergence of SARS-CoV-2 mutants has led to increased demand for variant profiling and monitoring in order to better understand changes to the virus’ characteristics and predict their impact on human health. This follows reports that while many genetic mutants of SARS-CoV-2 have shown little or no functional change, others, termed variants of concern, appear to be more transmissible and/or virulent. These variants could potentially impact the performance of current diagnostic approaches or the effectiveness of vaccines.

ValuPanel Reagents help detect SARS-CoV-2 and influenza

Industry News: LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up 26 Apr 2021 LGC, Biosearch Technologies has announced the release of a new set of ValuPanel™ Reagents to help the efforts of public health laboratories to detect SARS-CoV-2, influenza A, and influenza B. The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex ValuPanel Reagents - which are for research use only and not for use in diagnostic procedures - consists of probes and primers for multiplex RT-PCR detection and allows discrimination of SARS-CoV-2, influenza A, and influenza B from a single patient sample.

Covid-19 PCR test kits could soon be freeze-dried locally

SINGAPORE - The technique used to preserve food could prove to be a game changer in Singapore s fight against Covid-19 through the development of freeze-dried Covid-19 polymerase chain reaction (PCR) test kits, which would simplify storage and transportation requirements. Local biotech company BioAcumen Global said the key benefit of lyophilisation, as the technique is called, is that it removes the need for refrigeration currently required for Covid-19 PCR test kits. Freeze-dried kits can be kept at room temperature without any degradation. BioAcumen Global officially opened its new lyophilisation facility on Tuesday (March 16). It has the capacity to freeze-dry 2,400 PCR tests a day and hopes to double this capacity soon.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.